Literature DB >> 7966782

Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).

M L Cher1, T Ito, N Weidner, P R Carroll, R H Jensen.   

Abstract

Recent evidence suggests that a tumor suppressor gene important in the progression of prostatic carcinoma may reside on chromosome 16q. The exact location and identity of this gene are unknown. We used fluorescence in situ hybridization in a novel manner to define more clearly the location of this gene. Region-specific chromosome 16 cosmid contig probes were hybridized directly to interphase prostatic carcinoma nuclei in order to measure physical deletion of chromosomal loci. Fifteen of 30 tumors (50%) showed evidence of physical deletion of 16q24. Other probes were used to test for regions of chromosome 16 deletions in the same specimens, and a map showing a region of common deletion was created. This map showed the proximal terminus of the region of common deletion to be located distal to 16q23.1. These data correlate well with loss of heterozygosity data in the literature and provide further evidence for the presence of a prostatic carcinoma tumor suppressor gene on chromosome 16q.

Entities:  

Mesh:

Year:  1995        PMID: 7966782     DOI: 10.1097/00005392-199501000-00086

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).

Authors:  J A Doll; X Zhu; J Furman; Z Kaleem; C Torres; P A Humphrey; H Donis-Keller
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 3.  Review of allelic loss and gain in prostate cancer.

Authors:  G S Bova; W B Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

5.  Genetic alterations in hormone-refractory recurrent prostate carcinomas.

Authors:  N N Nupponen; L Kakkola; P Koivisto; T Visakorpi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

6.  WWOX, the common chromosomal fragile site, FRA16D, cancer gene.

Authors:  J H Ludes-Meyers; A K Bednarek; N C Popescu; M Bedford; C M Aldaz
Journal:  Cytogenet Genome Res       Date:  2003       Impact factor: 1.636

7.  Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.

Authors:  A M Cleton-Jansen; E W Moerland; J C Pronk; C G van Berkel; S Apostolou; J Crawford; A Savoia; A D Auerbach; C G Mathew; D F Callen; C J Cornelisse
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.

Authors:  René Böttcher; Charlotte F Kweldam; Julie Livingstone; Emilie Lalonde; Takafumi N Yamaguchi; Vincent Huang; Fouad Yousif; Michael Fraser; Robert G Bristow; Theodorus van der Kwast; Paul C Boutros; Guido Jenster; Geert J L H van Leenders
Journal:  BMC Cancer       Date:  2018-01-02       Impact factor: 4.430

9.  Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.

Authors:  Y Wada; M Igawa; H Shiina; K Shigeno; H Yokogi; S Urakami; T Yoneda; R Maruyama
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.